Novo Nordisk: Q4 Earnings Insights

 

Novo Nordisk NVO reported its Q4 earnings results on Wednesday, February 2, 2022 at 01:30 AM.

Here's what investors need to know about the announcement.

Earnings

Novo Nordisk beat estimated earnings by 2.82%, reporting an EPS of $0.73 versus an estimate of $0.71, which did not surprise analysts.

Revenue was up $754.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06, which was followed by a 0.25% increase in the share price the next day.

Here's a look at Novo Nordisk's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 0.78 0.77 0.83 0.64
EPS Actual 0.84 0.85 0.88 0.64
Revenue Estimate 5.35B 5.11B 5.29B 5.35B
Revenue Actual 5.64B 5.32B 5.48B 5.14B

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

NVO Logo
NVONovo Nordisk AS
$67.30-1.28%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
11.63
Growth
55.43
Quality
69.96
Value
6.68
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...